Data as of November 21, 2026

Vestura 3 mg-0.02 mg Tablet

DROSPIRENONE AND ETHINYL ESTRADIOL

Brand: Vestura

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$11.99/ fill$0.20 / EA
FUL
$22.20/ fill$0.36 / EA
AMP
$12.69/ fill$0.21 / EA
Medicaid FFS
$22.46/ fill
Medicaid MCO
$28.25/ fill

Sources: cms/nadac:price-ladder · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (61.3 units/fill)$11.99
Dispensing fee & other (state-fixed, not margin)$10.47
Total reimbursed per fill$22.46

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 1 fee-for-service states, 7 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-11-11; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology